SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of March, 2021
Commission File Number 001-39670
PURETECH HEALTH PLC
6 Tide Street, Suite 400
Boston, Massachusetts 02210
Attention: Chief Executive Officer
(617) 482-2333
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On March 15, 2021, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) issued a press release announcing its plans to announce its financial results for the year ended December 31, 2020 on Thursday, April 15, 2021. The press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.
Exhibits | ||
99.1 | Press Release dated March 15, 2021, “Notice of Results” |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PURETECH HEALTH PLC | ||||||
Date: March 15, 2021 | By: | /s/ Daphne Zohar | ||||
Name: Daphne Zohar | ||||||
Title: Chief Executive Officer |